It's worth keeping In mind that most of the costs associated with the last half yearly was in regards to the IPO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025